Now showing items 1-1 of 1

    • The use of digital pathology and image analysis in clinical trials. 

      Pell, R; Oien, K; Robinson, M; Pitman, H; Rajpoot, N; Rittscher, J; Snead, D; Verrill, C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) quality assurance working group (2019-04)
      Digital pathology and image analysis potentially provide greater accuracy, reproducibility and standardisation of pathology-based trial entry criteria and endpoints, alongside extracting new insights from both existing and ...